Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04891666Not ApplicableCompleted

A Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Children

Role: collaborator

NCT05596266Phase 1Unknown

CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia

Role: collaborator

NCT02303587Not ApplicableCompleted

Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP)

Role: collaborator

NCT04695275Unknown

Clinical Feature and Microbiology Characteristics of Empyema in Children

Role: collaborator

NCT03953638Unknown

Application of Next Generation Sequencing Technique in Pediatric Bacterial Meningitis

Role: collaborator

All 5 trials loaded